Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.

P L Martin, R J Wysocki Jr, R J Barrett, J M May and J Linden
Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 490-499;
P L Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R J Wysocki Jr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R J Barrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J M May
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Linden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 276 no. 2 490-499
PubMed 
8632314

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online February 1, 1996.


Author Information

  1. P L Martin,
  2. R J Wysocki, Jr,
  3. R J Barrett,
  4. J M May and
  5. J Linden
  1. Department of Pharmacology, Discovery Therapeutics Inc., Richmond, Virginia, USA.

    Statistics from Altmetric.com

    Article usage

    Article usage: July 1999 to April 2022

    AbstractFullPdf
    Jul 1999100
    Aug 1999100
    Dec 1999100
    Mar 2000100
    May 2000100
    Jun 2000200
    Jan 2001100
    Feb 2001100
    Mar 2001100
    May 2001200
    Jul 2001100
    Oct 2001300
    Jan 2002100
    Feb 2002100
    Mar 2002100
    Jul 2002300
    Oct 2002200
    Jan 2003300
    Mar 2003200
    Jun 2003200
    Jul 2003400
    Aug 2003600
    Sep 2003400
    Oct 2003700
    Nov 2003300
    Dec 2003300
    Jan 2004700
    Feb 2004700
    Mar 2004500
    Apr 2004700
    May 2004700
    Jun 2004500
    Jul 2004900
    Aug 2004800
    Sep 2004500
    Oct 2004600
    Nov 2004300
    Dec 2004200
    Jan 2005600
    Feb 2005100
    Mar 2005400
    Apr 2005300
    Jun 2005500
    Jul 2005400
    Aug 2005300
    Sep 2005500
    Oct 2005100
    Nov 2005600
    Dec 2005200
    Jan 2006300
    Feb 2006200
    Mar 2006201
    Apr 2006102
    May 2006301
    Jun 2006201
    Jul 2006200
    Aug 2006100
    Sep 2006501
    Nov 2006505
    Dec 2006100
    Jan 2007104
    Apr 2007001
    May 2007100
    Jun 2007002
    Jul 2007103
    Aug 2007701
    Sep 2007103
    Oct 2007002
    Nov 2007104
    Feb 2008205
    Mar 2008302
    Apr 2008100
    May 2008701
    Jun 2008401
    Jul 2008202
    Aug 2008201
    Sep 2008106
    Oct 2008502
    Nov 2008903
    Dec 2008409
    Jan 2009009
    Feb 2009209
    Mar 20098010
    Apr 20091014
    May 2009307
    Jun 2009203
    Jul 20094012
    Aug 2009203
    Sep 2009300
    Oct 2009500
    Nov 2009300
    Dec 2009500
    Jan 2010100
    Feb 2010400
    Mar 2010102
    Apr 2010503
    May 2010201
    Jun 2010300
    Jul 2010601
    Aug 2010201
    Sep 2010801
    Nov 2010100
    Dec 2010400
    Jan 2011300
    Feb 2011601
    Mar 2011300
    Apr 2011202
    May 2011700
    Jun 2011700
    Jul 2011301
    Aug 20111000
    Sep 2011500
    Oct 2011404
    Nov 2011901
    Dec 2011500
    Jan 2012002
    Feb 2012203
    Mar 20121405
    Apr 2012703
    May 2012701
    Jun 2012201
    Jul 2012600
    Sep 2012400
    Oct 2012501
    Nov 2012507
    Dec 2012301
    Jan 2013402
    Feb 2013600
    Mar 2013300
    Apr 2013503
    May 2013202
    Jun 2013200
    Jul 2013300
    Aug 2013301
    Sep 2013200
    Oct 2013304
    Nov 2013300
    Dec 2013200
    Jan 2014300
    Feb 2014700
    Mar 2014100
    Apr 2014501
    May 2014804
    Jun 2014200
    Jul 2014401
    Aug 2014200
    Oct 2014300
    Nov 20141100
    Dec 20141400
    Jan 2015100
    Feb 2015401
    Mar 2015100
    May 20152001
    Jun 2015002
    Jul 2015200
    Aug 2015101
    Sep 2015400
    Oct 2015100
    Dec 2015500
    Jan 2016601
    Feb 2016300
    Mar 2016800
    Apr 2016300
    May 2016100
    Jun 2016300
    Jul 2016200
    Sep 2016301
    Oct 20161802
    Nov 2016803
    Dec 2016200
    Jan 2017601
    Feb 2017500
    Mar 2017201
    Apr 2017700
    May 2017901
    Jun 2017700
    Jul 20171101
    Aug 2017800
    Sep 20171100
    Oct 2017900
    Nov 20171302
    Dec 2017400
    Jan 2018800
    Feb 2018200
    Mar 2018802
    Apr 2018901
    May 2018701
    Jun 2018901
    Jul 2018600
    Aug 2018600
    Sep 2018700
    Oct 2018600
    Nov 2018701
    Dec 2018100
    Jan 2019400
    Feb 20191301
    Mar 2019101
    Apr 2019100
    May 2019300
    Jun 2019103
    Jul 2019301
    Aug 2019601
    Sep 2019300
    Oct 2019600
    Nov 20191703
    Dec 2019200
    Jan 2020300
    Feb 2020600
    Mar 2020200
    Apr 2020400
    Jun 2020400
    Jul 2020100
    Sep 2020700
    Oct 2020100
    Nov 2020402
    Dec 2020500
    Jan 2021901
    Feb 2021901
    Mar 2021601
    Apr 2021500
    May 20211100
    Jun 2021601
    Jul 2021600
    Aug 20211000
    Sep 2021200
    Oct 20211002
    Nov 20211800
    Dec 2021701
    Jan 20221200
    Feb 2022200
    Mar 2022200
    Apr 20221300

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 276, Issue 2
    1 Feb 1996
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.

    P L Martin, R J Wysocki, R J Barrett, J M May and J Linden
    Journal of Pharmacology and Experimental Therapeutics February 1, 1996, 276 (2) 490-499;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.

    P L Martin, R J Wysocki, R J Barrett, J M May and J Linden
    Journal of Pharmacology and Experimental Therapeutics February 1, 1996, 276 (2) 490-499;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics